Key result
The FIMICS panel of 2906 long noncoding RNAs successfully differentiated failing from non-failing hearts and distinguished patients with myocarditis from those with acute myocardial infarction.
Why the study?
Patient stratification via novel biomarkers could improve cardiovascular disease management, and cardiac-enriched lncRNAs had emerged as potential tissue-specific biomarkers.
Can a panel of cardiac-enriched lncRNAs differentiate between cardiovascular conditions such as heart failure, myocarditis, and acute myocardial infarction?
Observational
Can a panel of cardiac-enriched lncRNAs differentiate between cardiovascular conditions such as heart failure, myocarditis, and acute myocardial infarction?
The FIMICS panel of 2906 lncRNAs may serve as a novel biomarker tool for diagnosing and monitoring cardiovascular conditions like heart failure, myocarditis, and acute myocardial infarction.
Answers are grounded in this paper and cite their sources.
FIMICS panel may support lncRNA biomarkers for cardiac conditions; hypothesis-generating from animal data, requiring prospective human validation before any clinical use.
Cardiovascular disorders such as heart failure are leading causes of mortality. Patient stratification via identification of novel biomarkers could improve management of cardiovascular diseases of complex etiologies. Long-noncoding RNAs (lncRNAs) are highly tissue-specific in nature and have emerged as important biomarkers in human diseases. In this study, we aimed to identify cardiac-enriched lncRNAs as potential biomarkers for cardiovascular conditions. Deep RNA sequencing and quantitative PCR identified differentially expressed lncRNAs between failing and non-failing hearts. An independent dataset was used to evaluate the enrichment of lncRNAs in normal hearts. We identified a panel of 2906 lncRNAs, named FIMICS, that were either cardiac-enriched or differentially expressed between failing and non-failing hearts. Expression of lncRNAs in blood samples differentiated patients with myocarditis and acute myocardial infarction. We hereby present the FIMICS panel, a readily available tool to provide insights into cardiovascular pathologies and which could be helpful for diagnosis, monitoring and prognosis purposes.
No takes yet. Share an insight, caveat, or question.
Firat et al. (2023) conducted an observational in Cardiovascular conditions. FIMICS panel of long noncoding RNAs vs. Non-failing hearts was evaluated on Differential expression of lncRNAs. The FIMICS panel of 2906 long noncoding RNAs successfully differentiated failing from non-failing hearts and distinguished patients with myocarditis from those with acute myocardial infarction.
Synapse has enriched 10 related papers. Consider them for comparative context: